Skip to main content

Security report for virotherapy.eu

International Virotherapy Center Limited · Healthcare · United Arab Emirates

Medium risk. 8 critical or high findings in Security headers, GDPR outside view and 1 other check.

Security score

52/100

Risk levelMedium

0–100, higher is better. How it is calculated

International Virotherapy Center Limited operates a professional website dedicated to oncolytic virotherapy, a novel cancer treatment approach using live viruses. The site provides extensive educational content, clinical publications, treatment and prevention information, and a contact center for patient inquiries. The company targets cancer patients, healthcare professionals, and researchers globally, positioning itself as a niche healthcare information provider. Technically, the website employs modern frontend technologies including Bootstrap, jQuery, RoyalSlider, and Swiper.js, with integrated analytics and marketing tools such as Google Analytics, Google Tag Manager, and Facebook Pixel. The site is mobile-optimized and offers a good user experience with clear navigation and relevant content. Security posture is moderate; HTTPS is used but no explicit security headers or published security policies are found. Privacy compliance is weak due to absence of privacy and cookie policies. WHOIS data is missing or unavailable, raising concerns about domain legitimacy despite the professional website presence. Overall, the site is functional and credible but would benefit from enhanced security and compliance transparency.

Scanned

NIS2 and GDPR posture

GDPR outside view
35/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

8 findings rated critical or high. Fix these first.

  1. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

  2. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Privacy Policy found

      GDPR requires a clear and accessible privacy policy

      What to do: Add a comprehensive privacy policy page and link to it prominently

    • High

      No Cookie Policy found

      GDPR requires clear information about cookie usage

      What to do: Add a dedicated cookie policy explaining cookie usage and purposes

Need hands-on remediation? Email guard@offseq.com

Keep watching virotherapy.eu

This scan found 24 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
85
Security headers
15
Email security
75
DNS health
80
Network security
20
GDPR outside view
35
Average
52

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The business operates in the healthcare sector focusing on oncolytic virotherapy, offering patient support, education, and access to scientific research. Its market position is specialized with a global outreach, leveraging partnerships such as with smartnanovirus.com for product promotion. Revenue streams likely include patient consultations and possibly product sales via partners. The company maintains active social media channels and publishes clinical data to build trust. Growth indicators include recent clinical publications and multimedia content. The partnership ecosystem is limited but strategic. Operationally, the company appears small but professional, with a clear focus on niche cancer treatment innovation.

Security posture

The website demonstrates a moderate security maturity level. HTTPS is implemented, ensuring encrypted communications. However, the absence of key security headers (CSP, HSTS, X-Frame-Options) and lack of visible anti-CSRF protections in forms represent vulnerabilities that could be exploited. No published security or incident response policies limit transparency and readiness. Privacy compliance is weak, with no privacy or cookie policies detected, potentially exposing the company to regulatory risks such as GDPR non-compliance. The use of third-party tracking scripts increases privacy risks. Overall, while no critical vulnerabilities are evident, improvements are needed to strengthen security posture and compliance.

Recommendations

  1. Implement and enforce HTTP security headers including Content Security Policy (CSP), HTTP Strict Transport Security (HSTS), X-Frame-Options, and X-XSS-Protection.
  2. Add anti-CSRF tokens and validation to all forms to prevent cross-site request forgery attacks.
  3. Publish comprehensive privacy and cookie policies detailing data collection, usage, and user rights to improve GDPR compliance.
  4. Establish and publish a security policy and incident response contact information to enhance transparency and preparedness.
  5. Verify and update WHOIS registration information to ensure domain legitimacy and trustworthiness.

Contact details published on the site

Addresses
Legal name
International Virotherapy Center Limited
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
International Virotherapy Center Limited
Description
International Virotherapy Center Limited provides information and services related to oncolytic virotherapy, a novel cancer treatment using live viruses. The website offers educational content, clinical publications, treatment and prevention information, and a contact center for inquiries.
Key services
Information dissemination about virotherapy and Rigvir, Patient inquiry and support via contact form and email, Access to scientific publications and clinical data, Educational videos and blog content
Content quality
good
Branding
consistent

Technology

Stack
Bootstrap CSS, jQuery, RoyalSlider, Swiper.js, Google Analytics, Google Tag Manager, Facebook Pixel
Frameworks
Bootstrap
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
65/100
Good practices seen
  • Use of HTTPS (implied by URL https://)
  • No visible exposed sensitive data in HTML
  • Secure form submission (form action empty but likely POST)

Analytics and tracking

Services
Google Analytics, Google Tag Manager, Facebook Pixel
Tracking level
moderate
Privacy practices
poor

Advertising

Ad networks
Google Ads
Tracking pixels
Facebook Pixel
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
moderate

Key observations

  1. Website is fully accessible with rich content and multimedia.
  2. No privacy or cookie policy pages detected, indicating potential compliance gaps.
  3. Contact information is clearly provided including email, phone, physical address, and contact form.
  4. No explicit security or incident response policies published.
  5. WHOIS data is missing or unavailable, which is unusual for an active domain.
  6. Use of multiple tracking and marketing scripts including Google Analytics and Facebook Pixel.
  7. Website uses modern frontend libraries and frameworks.
  8. No visible security headers detected in provided data.
  9. No CMS detected; likely custom or static site with Bootstrap and jQuery.
  10. No signs of WAF or blocking mechanisms.
Technical notes

Notes

The website uses a modern and responsive frontend technology stack including Bootstrap for layout and styling, jQuery for DOM manipulation, RoyalSlider and Swiper.js for interactive sliders, and Google Analytics and Facebook Pixel for analytics and marketing. The site is mobile-optimized with good navigation and content structure. No CMS is detected, suggesting a custom or static site architecture. Performance is moderate with asynchronous loading of scripts. However, the lack of security headers and anti-CSRF protections indicates technical debt in security implementation. The absence of WHOIS data may indicate privacy protection or data source limitations. Overall, the technical infrastructure supports the business goals but requires security and compliance enhancements.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with virotherapy.eu. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review virotherapy.eu.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.